Fosun to Bring Cutting-Edge Cancer Treatment to China – Caixin Global
Caixin Global |
Fosun to Bring Cutting-Edge Cancer Treatment to China
Caixin Global Yescarta is the brand name of a CAR T cell therapy, a type of adoptive cell transfer (ACT) treatment that is considered the “fifth pillar” of cancer treatment, along with drugs, surgery, chemotherapy and radiation. ACT is a form of immunotherapy that … |
